A new event, hosted by DDW and supported by Evotec, will explore cutting-edge LC-MS-based bioanalytical approaches tailored for the quantitative analysis of therapeutic proteins, such as monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), fusion protein biomarkers, and oligonucleotides in biological fluids and tissues.

The webinar, taking place on 27 March, will feature a presentation by Dr Marco Michi, Senior Research Leader for the discovery DMPK department at Evotec. Dr Michi brings more than 20 years of experience in the field, with extensive expertise in both regulated and discovery bioanalysis, including the implementation of innovative lean processes and advanced analytical technologies. In recent years, he has led the development and execution of Evotec’s DMPK bioanalytical strategy for biologics across multiple sites. He also oversees bioanalytical activities for the DMPK division at the company’s Italian location.

Register now to learn about:

• LC-MS method development and quantification strategies

– intact, hybrid, and direct digestion for therapeutic proteins

• ADC stability linker strategies
• ADC PK assays applied to micro-sampling
• Oligonucleotide quantification in plasma and tissues
• Case studies

This webinar will be moderated by Dino Montanari, VP Head of PK/PD, Modeling & Simulation at Evotec.

A live Q&A follows the webinar presentation.

Register now to secure your place.

The post Last chance to register: Understand LC-MS quantification strategies for proteins appeared first on Drug Discovery World (DDW).